Powered by lexis nexis

Cynvenio Biosystems and Color announce partnership to develop breast cancer test

Feb 23, 2017 - Marketline Newswire

Cynvenio Biosystems, Inc. and Color Genomics, Inc. have announced a partnership to offer the Color Test, a hereditary cancer panel that analyzes 30 genes including BRCA1 and BRCA2 with Concesio's ClearID Breast Cancer test, a specialized next-generation sequencing (NGS) panel that interrogates 27 genes for somatic mutations in breast cancer.

The combined Color and ClearID tests delivers a comprehensive approach for assessing hereditary breast cancer risk and monitoring patients at risk of ...